Please login or sign up to post and edit reviews.
How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation
Podcast |
Tradeoffs
Publisher |
Tradeoffs
Media Type |
audio
Categories Via RSS |
News
News & Politics
Science
Publication Date |
Apr 14, 2022
Episode Duration |
00:24:26

After Medicare’s decision to restrict coverage of the controversial new Alzheimer’s drug Aduhelm, we look at how this one drug has forced the nation to reexamine how to balance the needs of desperate patients, incomplete evidence and larger economic realities.

Guests:

Phil Gutis, Alzheimer’s patient and advocate

Holly Fernandez Lynch, JD, MBe, John Russell Dickson, MD Presidential Assistant Professor of Medical Ethics, University of Pennsylvania

Have a look at some additional resources and a full transcript.

Support this type of journalism today, with a gift.

Follow us on Twitter


Hosted on Acast. See acast.com/privacy for more information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review